The random and control study of CapeOX in 70-85 years old patient with radical resection of colorectal carcinoma

Trial Profile

The random and control study of CapeOX in 70-85 years old patient with radical resection of colorectal carcinoma

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Jul 2014

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
  • Indications Colorectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 May 2012 Planned end date changed from 31 Dec 2012 to 31 Dec 2017 as reported by Chinese Clinical Trial Register.
    • 24 Nov 2011 Status changed from recruiting to not yet recruiting as reported by Chinese Clinical Trial Register.
    • 11 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top